Skip to main content

25mg IG226 Pill - white capsule/oblong, 15mm

Pill with imprint 25mg IG226 is White, Capsule/Oblong and has been identified as Zonisamide 25 mg. It is supplied by Cipla USA, Inc.

Zonisamide is used in the treatment of Epilepsy; Seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 25mg IG226

Zonisamide

Imprint
25mg IG226
Strength
25 mg
Color
White
Size
15.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA, Inc.
Manufacturer
InvaGen Pharmaceuticals, Inc.
National Drug Code (NDC)
76282-0226
Inactive Ingredients
microcrystalline cellulose, hydrogenated castor oil, gelatin, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.